Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Chemours Company (The) Common Stock (NY:CC)

11.72 -0.05 (-0.47%)
Streaming Delayed Price Updated: 3:23 PM EST, Dec 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Chemours Company (The) Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
News headline image
This Fund Bought $63 Million of Chemours Stock Even as Shares Sit 80% Below 2017 Highs ↗
One hedge fund just made a bold bet on a beaten-down chemicals giant—here’s what long-term investors should know. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
XRP ETFs Ignite Market with Near-$1 Billion Debut, Signaling Robust Institutional Appetite
The cryptocurrency market is buzzing with the highly anticipated debut of several spot XRP Exchange-Traded Funds (ETFs), which have collectively surged towards an impressive $1 billion in assets under... 
Via BreakingCrypto
Topics ETFs Economy Regulatory Compliance
News headline image
Fund Adds $7.2 Million Powell Stake as the Electrical Supplier Posts Record $181 Million Profit ↗
One industrial supplier just posted a record year—and a concentrated fund quietly built a new stake. 
Via The Motley Fool
Topics Regulatory Compliance Supply Chain
News headline image
Earnings Scheduled For November 6, 2025 ↗
 
Via Benzinga
News headline image
Where Chemours Stands With Analysts ↗
 
Via Benzinga
News headline image
Beyond The Numbers: 4 Analysts Discuss Chemours Stock ↗
 
Via Benzinga
News headline image
This Fund Just Took a $5.5 Million Stake in a Turnaround Stock Up 143% This Past Year ↗
One fund just made a contrarian bet on an industrial turnaround story—here’s what long-term investors should watch next. 
Via The Motley Fool
News headline image
Top 3 Materials Stocks That Are Preparing To Pump In Q4 ↗
 
Via Benzinga
News headline image
Chemours (NYSE:CC) Q3 2025 Earnings Miss Estimates, Stock Falls on Weak Guidance ↗
Chemours (CC) missed Q3 2025 earnings estimates, with EPS of $0.20 vs. $0.26 expected. Strong Opteon™ sales were offset by weak performance in other segments and a cautious Q4 outlook. 
Via Chartmill
Topics Earnings
News headline image
Investment Company Luminus Loaded Up on This Leading Industrials Stock. Is It a Buy? ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Earnings Scheduled For August 5, 2025 ↗
 
Via Benzinga
News headline image
A Look at Chemours's Upcoming Earnings Report ↗
 
Via Benzinga
News headline image
Assessing Chemours: Insights From 8 Financial Analysts ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 6, 2025 ↗
 
Via Benzinga
News headline image
Luminus Dumps About 43,000 Quaker Chemical Shares Worth $5.6 Million ↗
Via The Motley Fool
Topics Regulatory Compliance World Trade
News headline image
Luminus Trims Its Hefty Chemours Position ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
3 Industrial Stocks Ready to Benefit From Fed Cuts and Spending ↗
Industrial stocks have started to pick up the pace in terms of price action, yet they are not even close to pricing in the growth potential 
Via MarketBeat
Topics Economy Stocks World Trade
News headline image
Agri-Science Giant Corteva Eyes Breakup To Shield Seed Unit From Future Risks: Report ↗
Corteva is exploring a breakup that would separate its seed and pesticide businesses. The move could reshape agriculture amid falling crop prices and rising costs. 
Via Benzinga
News headline image
How Do Investors Really Feel About Chemours? ↗
 
Via Benzinga
News headline image
DuPont Divests Aramids Business In $1.8 Billion Deal To Sharpen Portfolio ↗
DuPont agreed to sell its Aramids business, including Kevlar and Nomex brands, to Arclin for $1.8B. Deal aligns with DuPont's strategy to improve profitability and shareholders to benefit from Arclin's... 
Via Benzinga
News headline image
Chemours (CC) Q2 EPS Jumps 53% ↗
Via The Motley Fool
News headline image
Why ENDRA Life Sciences Shares Are Trading Higher By Over 61%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Analyst Expectations For Chemours's Future ↗
 
Via Benzinga
News headline image
Wall Street's Most Accurate Analysts Give Their Take On 3 Materials Stocks Delivering High-Dividend Yields ↗
 
Via Benzinga
News headline image
6 Analysts Assess Chemours: What You Need To Know ↗
 
Via Benzinga
News headline image
Chemours Slides After Dividend Cut, Q1 Profit Miss: Retail’s Split As Management Bets On Data Center Cooling ↗
The specialty chemicals firm reported a net loss of $4 million, or $0.03 per share, compared with a profit of $54 million, or $0.36 per share, a year earlier. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
Get insights into the top gainers and losers of Wednesday's after-hours session. ↗
As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment. 
Via Chartmill
News headline image
Wall Street's Most Accurate Analysts Weigh In On 3 Materials Stocks With Over 7% Dividend Yields ↗
 
Via Benzinga
News headline image
What 6 Analyst Ratings Have To Say About Chemours ↗
 
Via Benzinga
News headline image
This Check Point Software Analyst Turns Bullish; Here Are Top 3 Upgrades For Thursday ↗
 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.